MGMT and central nervous system cancer: However, epigenetic silencing of MGMT is common in gliomas [2, 3], and gliomas with low MGMT levels (deficiency and low-expression) are still sufficient to confer TMZ-R [4], suggesting the existence of an MGMT-independent mechanism of acquired TMZ-R.